APO Research
Talk to an analyst

APO RESEARCH · REPORT

Non-opioid Pain Patch

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Non-opioid Pain Patch Market Analysis and Forecast 2026-2032

20 December 2025201 pages

Choose your research edition.

Industry ResearchNon-opioid Pain Patch Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-opioid Pain Patch Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Non-opioid Pain Patch Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-opioid Pain Patch Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Non-opioid Pain Patch Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Non-opioid Pain Patch market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Non-opioid Pain Patch is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Non-opioid Pain Patch is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Non-opioid Pain Patch is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Non-opioid Pain Patch is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Non-opioid Pain Patch include Sanofi, Johnson & Johnson, Qizheng, Novartis, Mylan, Lingrui, Huarun 999, GSK and Teikoku Seiyaku, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Non-opioid Pain Patch, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Non-opioid Pain Patch, also provides the sales of main regions and countries. Of the upcoming market potential for Non-opioid Pain Patch, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Non-opioid Pain Patch sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Non-opioid Pain Patch market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Non-opioid Pain Patch sales, projected growth trends, production technology, application and end-user industry.

Non-opioid Pain Patch Segment by Company

Sanofi

Johnson & Johnson

Qizheng

Novartis

Mylan

Lingrui

Huarun 999

GSK

Teikoku Seiyaku

Nichiban

Mentholatum

Laboratoires Genevrier

Hisamitsu

Haw Par

Endo

BLUE-EMU

Actavis

Non-opioid Pain Patch Segment by Type

Fentanyl Patches

Counter-Irritant Patches

Lidocaine Patches

Diclofenac Patches

Indomethacin Patches

Others

Non-opioid Pain Patch Segment by Application

OTC

Rx

Non-opioid Pain Patch Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-opioid Pain Patch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-opioid Pain Patch and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-opioid Pain Patch.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Non-opioid Pain Patch in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Non-opioid Pain Patch manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Non-opioid Pain Patch sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Non-opioid Pain Patch Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Fentanyl Patches Major Manufacturers Table 3. Counter-Irritant Patches Major Manufacturers Table 4. Lidocaine Patches Major Manufacturers Table 5. Diclofenac Patches Major Manufacturers Table 6. Indomethacin Patches Major Manufacturers Table 7. Others Major Manufacturers Table 8. Global Non-opioid Pain Patch Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. OTC Major Manufacturers Table 10. Rx Major Manufacturers Table 11. Non-opioid Pain Patch Industry Trends Table 12. Non-opioid Pain Patch Industry Drivers Table 13. Non-opioid Pain Patch Industry Opportunities and Challenges Table 14. Non-opioid Pain Patch Industry Restraints Table 15. Global Non-opioid Pain Patch Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Non-opioid Pain Patch Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Non-opioid Pain Patch Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Non-opioid Pain Patch Revenue Market Share by Region (2021-2026) Table 19. Global Non-opioid Pain Patch Revenue Market Share by Region (2027-2032) Table 20. Global Non-opioid Pain Patch Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (M Pcs) Table 21. Global Non-opioid Pain Patch Sales by Region (2021-2026) & (M Pcs) Table 22. Global Non-opioid Pain Patch Sales by Region (2027-2032) & (M Pcs) Table 23. Global Non-opioid Pain Patch Sales Market Share by Region (2021-2026) Table 24. Global Non-opioid Pain Patch Sales Market Share by Region (2027-2032) Table 25. Global Non-opioid Pain Patch Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Non-opioid Pain Patch Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Non-opioid Pain Patch Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Non-opioid Pain Patch Sales Market Share by Manufacturers (2021-2026) Table 29. Global Non-opioid Pain Patch Sales Price (US$/Pcs) of Manufacturers (2021-2026) Table 30. Global Non-opioid Pain Patch Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Non-opioid Pain Patch Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Non-opioid Pain Patch Manufacturers, Product Type & Application Table 33. Global Non-opioid Pain Patch Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Non-opioid Pain Patch by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Non-opioid Pain Patch Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Non-opioid Pain Patch Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Non-opioid Pain Patch Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Non-opioid Pain Patch Revenue Market Share by Type (2021-2026) Table 40. Global Non-opioid Pain Patch Revenue Market Share by Type (2027-2032) Table 41. Global Non-opioid Pain Patch Sales by Type 2021 VS 2025 VS 2032 (M Pcs) Table 42. Global Non-opioid Pain Patch Sales by Type (2021-2026) & (M Pcs) Table 43. Global Non-opioid Pain Patch Sales by Type (2027-2032) & (M Pcs) Table 44. Global Non-opioid Pain Patch Sales Market Share by Type (2021-2026) Table 45. Global Non-opioid Pain Patch Sales Market Share by Type (2027-2032) Table 46. Global Non-opioid Pain Patch Price by Type (2021-2026) & (US$/Pcs) Table 47. Global Non-opioid Pain Patch Price by Type (2027-2032) & (US$/Pcs) Table 48. Global Non-opioid Pain Patch Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Non-opioid Pain Patch Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Non-opioid Pain Patch Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Non-opioid Pain Patch Revenue Market Share by Application (2021-2026) Table 52. Global Non-opioid Pain Patch Revenue Market Share by Application (2027-2032) Table 53. Global Non-opioid Pain Patch Sales by Application 2021 VS 2025 VS 2032 (M Pcs) Table 54. Global Non-opioid Pain Patch Sales by Application (2021-2026) & (M Pcs) Table 55. Global Non-opioid Pain Patch Sales by Application (2027-2032) & (M Pcs) Table 56. Global Non-opioid Pain Patch Sales Market Share by Application (2021-2026) Table 57. Global Non-opioid Pain Patch Sales Market Share by Application (2027-2032) Table 58. Global Non-opioid Pain Patch Price by Application (2021-2026) & (US$/Pcs) Table 59. Global Non-opioid Pain Patch Price by Application (2027-2032) & (US$/Pcs) Table 60. Sanofi Company Information Table 61. Sanofi Business Overview Table 62. Sanofi Non-opioid Pain Patch Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 63. Sanofi Non-opioid Pain Patch Product Portfolio Table 64. Sanofi Recent Development Table 65. Johnson & Johnson Company Information Table 66. Johnson & Johnson Business Overview Table 67. Johnson & Johnson Non-opioid Pain Patch Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 68. Johnson & Johnson Non-opioid Pain Patch Product Portfolio Table 69. Johnson & Johnson Recent Development Table 70. Qizheng Company Information Table 71. Qizheng Business Overview Table 72. Qizheng Non-opioid Pain Patch Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 73. Qizheng Non-opioid Pain Patch Product Portfolio Table 74. Qizheng Recent Development Table 75. Novartis Company Information Table 76. Novartis Business Overview Table 77. Novartis Non-opioid Pain Patch Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 78. Novartis Non-opioid Pain Patch Product Portfolio Table 79. Novartis Recent Development Table 80. Mylan Company Information Table 81. Mylan Business Overview Table 82. Mylan Non-opioid Pain Patch Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 83. Mylan Non-opioid Pain Patch Product Portfolio Table 84. Mylan Recent Development Table 85. Lingrui Company Information Table 86. Lingrui Business Overview Table 87. Lingrui Non-opioid Pain Patch Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 88. Lingrui Non-opioid Pain Patch Product Portfolio Table 89. Lingrui Recent Development Table 90. Huarun 999 Company Information Table 91. Huarun 999 Business Overview Table 92. Huarun 999 Non-opioid Pain Patch Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 93. Huarun 999 Non-opioid Pain Patch Product Portfolio Table 94. Huarun 999 Recent Development Table 95. GSK Company Information Table 96. GSK Business Overview Table 97. GSK Non-opioid Pain Patch Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 98. GSK Non-opioid Pain Patch Product Portfolio Table 99. GSK Recent Development Table 100. Teikoku Seiyaku Company Information Table 101. Teikoku Seiyaku Business Overview Table 102. Teikoku Seiyaku Non-opioid Pain Patch Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 103. Teikoku Seiyaku Non-opioid Pain Patch Product Portfolio Table 104. Teikoku Seiyaku Recent Development Table 105. Nichiban Company Information Table 106. Nichiban Business Overview Table 107. Nichiban Non-opioid Pain Patch Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 108. Nichiban Non-opioid Pain Patch Product Portfolio Table 109. Nichiban Recent Development Table 110. Mentholatum Company Information Table 111. Mentholatum Business Overview Table 112. Mentholatum Non-opioid Pain Patch Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 113. Mentholatum Non-opioid Pain Patch Product Portfolio Table 114. Mentholatum Recent Development Table 115. Laboratoires Genevrier Company Information Table 116. Laboratoires Genevrier Business Overview Table 117. Laboratoires Genevrier Non-opioid Pain Patch Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 118. Laboratoires Genevrier Non-opioid Pain Patch Product Portfolio Table 119. Laboratoires Genevrier Recent Development Table 120. Hisamitsu Company Information Table 121. Hisamitsu Business Overview Table 122. Hisamitsu Non-opioid Pain Patch Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 123. Hisamitsu Non-opioid Pain Patch Product Portfolio Table 124. Hisamitsu Recent Development Table 125. Haw Par Company Information Table 126. Haw Par Business Overview Table 127. Haw Par Non-opioid Pain Patch Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 128. Haw Par Non-opioid Pain Patch Product Portfolio Table 129. Haw Par Recent Development Table 130. Endo Company Information Table 131. Endo Business Overview Table 132. Endo Non-opioid Pain Patch Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 133. Endo Non-opioid Pain Patch Product Portfolio Table 134. Endo Recent Development Table 135. BLUE-EMU Company Information Table 136. BLUE-EMU Business Overview Table 137. BLUE-EMU Non-opioid Pain Patch Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 138. BLUE-EMU Non-opioid Pain Patch Product Portfolio Table 139. BLUE-EMU Recent Development Table 140. Actavis Company Information Table 141. Actavis Business Overview Table 142. Actavis Non-opioid Pain Patch Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 143. Actavis Non-opioid Pain Patch Product Portfolio Table 144. Actavis Recent Development Table 145. North America Non-opioid Pain Patch Revenue by Type (2021-2026) & (US$ Million) Table 146. North America Non-opioid Pain Patch Revenue by Type (2027-2032) & (US$ Million) Table 147. North America Non-opioid Pain Patch Sales by Type (2021-2026) & (M Pcs) Table 148. North America Non-opioid Pain Patch Sales by Type (2027-2032) & (M Pcs) Table 149. North America Non-opioid Pain Patch Sales Price by Type (2021-2026) & (US$/Pcs) Table 150. North America Non-opioid Pain Patch Sales Price by Type (2027-2032) & (US$/Pcs) Table 151. North America Non-opioid Pain Patch Revenue by Application (2021-2026) & (US$ Million) Table 152. North America Non-opioid Pain Patch Revenue by Application (2027-2032) & (US$ Million) Table 153. North America Non-opioid Pain Patch Sales by Application (2021-2026) & (M Pcs) Table 154. North America Non-opioid Pain Patch Sales by Application (2027-2032) & (M Pcs) Table 155. North America Non-opioid Pain Patch Sales Price by Application (2021-2026) & (US$/Pcs) Table 156. North America Non-opioid Pain Patch Sales Price by Application (2027-2032) & (US$/Pcs) Table 157. North America Non-opioid Pain Patch Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 158. North America Non-opioid Pain Patch Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 159. North America Non-opioid Pain Patch Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 160. North America Non-opioid Pain Patch Sales by Country (2021 VS 2025 VS 2032) & (M Pcs) Table 161. North America Non-opioid Pain Patch Sales by Country (2021-2026) & (M Pcs) Table 162. North America Non-opioid Pain Patch Sales by Country (2027-2032) & (M Pcs) Table 163. North America Non-opioid Pain Patch Sales Price by Country (2021-2026) & (US$/Pcs) Table 164. North America Non-opioid Pain Patch Sales Price by Country (2027-2032) & (US$/Pcs) Table 165. United States Non-opioid Pain Patch Revenue (2021-2032) & (US$ Million) Table 166. Canada Non-opioid Pain Patch Revenue (2021-2032) & (US$ Million) Table 167. Europe Non-opioid Pain Patch Revenue by Type (2021-2026) & (US$ Million) Table 168. Europe Non-opioid Pain Patch Revenue by Type (2027-2032) & (US$ Million) Table 169. Europe Non-opioid Pain Patch Sales by Type (2021-2026) & (M Pcs) Table 170. Europe Non-opioid Pain Patch Sales by Type (2027-2032) & (M Pcs) Table 171. Europe Non-opioid Pain Patch Sales Price by Type (2021-2026) & (US$/Pcs) Table 172. Europe Non-opioid Pain Patch Sales Price by Type (2027-2032) & (US$/Pcs) Table 173. Europe Non-opioid Pain Patch Revenue by Application (2021-2026) & (US$ Million) Table 174. Europe Non-opioid Pain Patch Revenue by Application (2027-2032) & (US$ Million) Table 175. Europe Non-opioid Pain Patch Sales by Application (2021-2026) & (M Pcs) Table 176. Europe Non-opioid Pain Patch Sales by Application (2027-2032) & (M Pcs) Table 177. Europe Non-opioid Pain Patch Sales Price by Application (2021-2026) & (US$/Pcs) Table 178. Europe Non-opioid Pain Patch Sales Price by Application (2027-2032) & (US$/Pcs) Table 179. Europe Non-opioid Pain Patch Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 180. Europe Non-opioid Pain Patch Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 181. Europe Non-opioid Pain Patch Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 182. Europe Non-opioid Pain Patch Sales by Country (2021 VS 2025 VS 2032) & (M Pcs) Table 183. Europe Non-opioid Pain Patch Sales by Country (2021-2026) & (M Pcs) Table 184. Europe Non-opioid Pain Patch Sales by Country (2027-2032) & (M Pcs) Table 185. Europe Non-opioid Pain Patch Sales Price by Country (2021-2026) & (US$/Pcs) Table 186. Europe Non-opioid Pain Patch Sales Price by Country (2027-2032) & (US$/Pcs) Table 187. Germany Non-opioid Pain Patch Revenue (2021-2032) & (US$ Million) Table 188. France Non-opioid Pain Patch Revenue (2021-2032) & (US$ Million) Table 189. U.K. Non-opioid Pain Patch Revenue (2021-2032) & (US$ Million) Table 190. Italy Non-opioid Pain Patch Revenue (2021-2032) & (US$ Million) Table 191. Netherlands Non-opioid Pain Patch Revenue (2021-2032) & (US$ Million) Table 192. Nordic Countries Non-opioid Pain Patch Revenue (2021-2032) & (US$ Million) Table 193. China Non-opioid Pain Patch Revenue by Type (2021-2026) & (US$ Million) Table 194. China Non-opioid Pain Patch Revenue by Type (2027-2032) & (US$ Million) Table 195. China Non-opioid Pain Patch Sales by Type (2021-2026) & (M Pcs) Table 196. China Non-opioid Pain Patch Sales by Type (2027-2032) & (M Pcs) Table 197. China Non-opioid Pain Patch Sales Price by Type (2021-2026) & (US$/Pcs) Table 198. China Non-opioid Pain Patch Sales Price by Type (2027-2032) & (US$/Pcs) Table 199. China Non-opioid Pain Patch Revenue by Application (2021-2026) & (US$ Million) Table 200. China Non-opioid Pain Patch Revenue by Application (2027-2032) & (US$ Million) Table 201. China Non-opioid Pain Patch Sales by Application (2021-2026) & (M Pcs) Table 202. China Non-opioid Pain Patch Sales by Application (2027-2032) & (M Pcs) Table 203. China Non-opioid Pain Patch Sales Price by Application (2021-2026) & (US$/Pcs) Table 204. China Non-opioid Pain Patch Sales Price by Application (2027-2032) & (US$/Pcs) Table 205. Asia Non-opioid Pain Patch Revenue by Type (2021-2026) & (US$ Million) Table 206. Asia Non-opioid Pain Patch Revenue by Type (2027-2032) & (US$ Million) Table 207. Asia Non-opioid Pain Patch Sales by Type (2021-2026) & (M Pcs) Table 208. Asia Non-opioid Pain Patch Sales by Type (2027-2032) & (M Pcs) Table 209. Asia Non-opioid Pain Patch Sales Price by Type (2021-2026) & (US$/Pcs) Table 210. Asia Non-opioid Pain Patch Sales Price by Type (2027-2032) & (US$/Pcs) Table 211. Asia Non-opioid Pain Patch Revenue by Application (2021-2026) & (US$ Million) Table 212. Asia Non-opioid Pain Patch Revenue by Application (2027-2032) & (US$ Million) Table 213. Asia Non-opioid Pain Patch Sales by Application (2021-2026) & (M Pcs) Table 214. Asia Non-opioid Pain Patch Sales by Application (2027-2032) & (M Pcs) Table 215. Asia Non-opioid Pain Patch Sales Price by Application (2021-2026) & (US$/Pcs) Table 216. Asia Non-opioid Pain Patch Sales Price by Application (2027-2032) & (US$/Pcs) Table 217. Asia Non-opioid Pain Patch Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 218. Asia Non-opioid Pain Patch Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 219. Asia Non-opioid Pain Patch Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 220. Asia Non-opioid Pain Patch Sales by Country (2021 VS 2025 VS 2032) & (M Pcs) Table 221. Asia Non-opioid Pain Patch Sales by Country (2021-2026) & (M Pcs) Table 222. Asia Non-opioid Pain Patch Sales by Country (2027-2032) & (M Pcs) Table 223. Asia Non-opioid Pain Patch Sales Price by Country (2021-2026) & (US$/Pcs) Table 224. Asia Non-opioid Pain Patch Sales Price by Country (2027-2032) & (US$/Pcs) Table 225. Japan Non-opioid Pain Patch Revenue (2021-2032) & (US$ Million) Table 226. South Korea Non-opioid Pain Patch Revenue (2021-2032) & (US$ Million) Table 227. India Non-opioid Pain Patch Revenue (2021-2032) & (US$ Million) Table 228. Australia Non-opioid Pain Patch Revenue (2021-2032) & (US$ Million) Table 229. China Taiwan Non-opioid Pain Patch Revenue (2021-2032) & (US$ Million) Table 230. Southeast Asia Non-opioid Pain Patch Revenue (2021-2032) & (US$ Million) Table 231. SAMEA Non-opioid Pain Patch Revenue by Type (2021-2026) & (US$ Million) Table 232. SAMEA Non-opioid Pain Patch Revenue by Type (2027-2032) & (US$ Million) Table 233. SAMEA Non-opioid Pain Patch Sales by Type (2021-2026) & (M Pcs) Table 234. SAMEA Non-opioid Pain Patch Sales by Type (2027-2032) & (M Pcs) Table 235. SAMEA Non-opioid Pain Patch Sales Price by Type (2021-2026) & (US$/Pcs) Table 236. SAMEA Non-opioid Pain Patch Sales Price by Type (2027-2032) & (US$/Pcs) Table 237. SAMEA Non-opioid Pain Patch Revenue by Application (2021-2026) & (US$ Million) Table 238. SAMEA Non-opioid Pain Patch Revenue by Application (2027-2032) & (US$ Million) Table 239. SAMEA Non-opioid Pain Patch Sales by Application (2021-2026) & (M Pcs) Table 240. SAMEA Non-opioid Pain Patch Sales by Application (2027-2032) & (M Pcs) Table 241. SAMEA Non-opioid Pain Patch Sales Price by Application (2021-2026) & (US$/Pcs) Table 242. SAMEA Non-opioid Pain Patch Sales Price by Application (2027-2032) & (US$/Pcs) Table 243. SAMEA Non-opioid Pain Patch Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 244. SAMEA Non-opioid Pain Patch Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 245. SAMEA Non-opioid Pain Patch Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 246. SAMEA Non-opioid Pain Patch Sales by Country (2021 VS 2025 VS 2032) & (M Pcs) Table 247. SAMEA Non-opioid Pain Patch Sales by Country (2021-2026) & (M Pcs) Table 248. SAMEA Non-opioid Pain Patch Sales by Country (2027-2032) & (M Pcs) Table 249. SAMEA Non-opioid Pain Patch Sales Price by Country (2021-2026) & (US$/Pcs) Table 250. SAMEA Non-opioid Pain Patch Sales Price by Country (2027-2032) & (US$/Pcs) Table 251. Brazil Non-opioid Pain Patch Revenue (2021-2032) & (US$ Million) Table 252. Argentina Non-opioid Pain Patch Revenue (2021-2032) & (US$ Million) Table 253. Chile Non-opioid Pain Patch Revenue (2021-2032) & (US$ Million) Table 254. Colombia Non-opioid Pain Patch Revenue (2021-2032) & (US$ Million) Table 255. Peru Non-opioid Pain Patch Revenue (2021-2032) & (US$ Million) Table 256. Saudi Arabia Non-opioid Pain Patch Revenue (2021-2032) & (US$ Million) Table 257. Israel Non-opioid Pain Patch Revenue (2021-2032) & (US$ Million) Table 258. UAE Non-opioid Pain Patch Revenue (2021-2032) & (US$ Million) Table 259. Turkey Non-opioid Pain Patch Revenue (2021-2032) & (US$ Million) Table 260. Iran Non-opioid Pain Patch Revenue (2021-2032) & (US$ Million) Table 261. Egypt Non-opioid Pain Patch Revenue (2021-2032) & (US$ Million) Table 262. Key Raw Materials Table 263. Raw Materials Key Suppliers Table 264. Non-opioid Pain Patch Distributors List Table 265. Non-opioid Pain Patch Customers List Table 266. Research Programs/Design for This Report Table 267. Authors List of This Report Table 268. Secondary Sources Table 269. Primary Sources List of Figures Figure 1. Non-opioid Pain Patch Image Figure 2. Global Non-opioid Pain Patch Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non-opioid Pain Patch Market Size Share 2021 VS 2025 VS 2032 Figure 4. Fentanyl Patches Image Figure 5. Counter-Irritant Patches Image Figure 6. Lidocaine Patches Image Figure 7. Diclofenac Patches Image Figure 8. Indomethacin Patches Image Figure 9. Others Image Figure 10. Global Non-opioid Pain Patch Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Non-opioid Pain Patch Market Size Share 2021 VS 2025 VS 2032 Figure 12. OTC Image Figure 13. Rx Image Figure 14. Global Non-opioid Pain Patch Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Non-opioid Pain Patch Revenue (2021-2032) & (US$ Million) Figure 16. Global Non-opioid Pain Patch Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Non-opioid Pain Patch Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Non-opioid Pain Patch Revenue Market Share by Region (2021-2032) Figure 19. Global Non-opioid Pain Patch Sales (2021-2032) & (M Pcs) Figure 20. Global Non-opioid Pain Patch Sales by Region: 2021 VS 2025 VS 2032 (M Pcs) Figure 21. Global Non-opioid Pain Patch Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Non-opioid Pain Patch Sales YoY (2021-2032) & (M Pcs) Figure 23. Europe Non-opioid Pain Patch Sales YoY (2021-2032) & (M Pcs) Figure 24. China Non-opioid Pain Patch Sales YoY (2021-2032) & (M Pcs) Figure 25. Asia (Excluding China) Non-opioid Pain Patch Sales YoY (2021-2032) & (M Pcs) Figure 26. South America, Middle East and Africa Non-opioid Pain Patch Sales YoY (2021-2032) & (M Pcs) Figure 27. Global Non-opioid Pain Patch Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Non-opioid Pain Patch Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Non-opioid Pain Patch Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Non-opioid Pain Patch Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Non-opioid Pain Patch Revenue Market Share by Type (2021-2032) Figure 33. Global Non-opioid Pain Patch Sales by Type (2021 VS 2025 VS 2032) & (M Pcs) Figure 34. Global Non-opioid Pain Patch Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Non-opioid Pain Patch Sales Market Share by Type (2021-2032) Figure 36. Global Non-opioid Pain Patch Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Non-opioid Pain Patch Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Non-opioid Pain Patch Revenue Market Share by Application (2021-2032) Figure 39. Global Non-opioid Pain Patch Sales by Application (2021 VS 2025 VS 2032) & (M Pcs) Figure 40. Global Non-opioid Pain Patch Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Non-opioid Pain Patch Sales Market Share by Application (2021-2032) Figure 42. North America Non-opioid Pain Patch Revenue Share by Type (2021-2032) Figure 43. North America Non-opioid Pain Patch Sales Share by Type (2021-2032) Figure 44. North America Non-opioid Pain Patch Revenue Share by Application (2021-2032) Figure 45. North America Non-opioid Pain Patch Sales Share by Application (2021-2032) Figure 46. North America Non-opioid Pain Patch Revenue Share by Country (2021-2032) Figure 47. North America Non-opioid Pain Patch Sales Share by Country (2021-2032) Figure 48. Europe Non-opioid Pain Patch Revenue Share by Type (2021-2032) Figure 49. Europe Non-opioid Pain Patch Sales Share by Type (2021-2032) Figure 50. Europe Non-opioid Pain Patch Revenue Share by Application (2021-2032) Figure 51. Europe Non-opioid Pain Patch Sales Share by Application (2021-2032) Figure 52. Europe Non-opioid Pain Patch Revenue Share by Country (2021-2032) Figure 53. Europe Non-opioid Pain Patch Sales Share by Country (2021-2032) Figure 54. China Non-opioid Pain Patch Revenue Share by Type (2021-2032) Figure 55. China Non-opioid Pain Patch Sales Share by Type (2021-2032) Figure 56. China Non-opioid Pain Patch Revenue Share by Application (2021-2032) Figure 57. China Non-opioid Pain Patch Sales Share by Application (2021-2032) Figure 58. Asia Non-opioid Pain Patch Revenue Share by Type (2021-2032) Figure 59. Asia Non-opioid Pain Patch Sales Share by Type (2021-2032) Figure 60. Asia Non-opioid Pain Patch Revenue Share by Application (2021-2032) Figure 61. Asia Non-opioid Pain Patch Sales Share by Application (2021-2032) Figure 62. Asia Non-opioid Pain Patch Revenue Share by Country (2021-2032) Figure 63. Asia Non-opioid Pain Patch Sales Share by Country (2021-2032) Figure 64. SAMEA Non-opioid Pain Patch Revenue Share by Type (2021-2032) Figure 65. SAMEA Non-opioid Pain Patch Sales Share by Type (2021-2032) Figure 66. SAMEA Non-opioid Pain Patch Revenue Share by Application (2021-2032) Figure 67. SAMEA Non-opioid Pain Patch Sales Share by Application (2021-2032) Figure 68. SAMEA Non-opioid Pain Patch Revenue Share by Country (2021-2032) Figure 69. SAMEA Non-opioid Pain Patch Sales Share by Country (2021-2032) Figure 70. Non-opioid Pain Patch Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Non-opioid Pain Patch Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Fentanyl Patches
  • Counter-Irritant Patches
  • Lidocaine Patches
  • Diclofenac Patches
  • Indomethacin Patches
  • Others
Applications
  • OTC
  • Rx
Companies covered
  • Sanofi
  • Johnson & Johnson
  • Qizheng
  • Novartis
  • Mylan
  • Lingrui
  • Huarun 999
  • GSK
  • Teikoku Seiyaku
  • Nichiban
  • Mentholatum
  • Laboratoires Genevrier
  • Hisamitsu
  • Haw Par
  • Endo
  • BLUE-EMU
  • Actavis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Non-opioid Pain Patch Market by Type
  3. 1.2.1 Global Non-opioid Pain Patch Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Fentanyl Patches
  5. 1.2.3 Counter-Irritant Patches
  6. 1.2.4 Lidocaine Patches
  7. 1.2.5 Diclofenac Patches
  8. 1.2.6 Indomethacin Patches
  9. 1.2.7 Others
  10. 1.3 Non-opioid Pain Patch Market by Application
  11. 1.3.1 Global Non-opioid Pain Patch Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 OTC
  13. 1.3.3 Rx
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Non-opioid Pain Patch Market Dynamics
  1. 2.1 Non-opioid Pain Patch Industry Trends
  2. 2.2 Non-opioid Pain Patch Industry Drivers
  3. 2.3 Non-opioid Pain Patch Industry Opportunities and Challenges
  4. 2.4 Non-opioid Pain Patch Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Non-opioid Pain Patch Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Non-opioid Pain Patch Revenue by Region
  3. 3.2.1 Global Non-opioid Pain Patch Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Non-opioid Pain Patch Revenue by Region (2021-2026)
  5. 3.2.3 Global Non-opioid Pain Patch Revenue by Region (2027-2032)
  6. 3.2.4 Global Non-opioid Pain Patch Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Non-opioid Pain Patch Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Non-opioid Pain Patch Sales by Region
  9. 3.4.1 Global Non-opioid Pain Patch Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Non-opioid Pain Patch Sales by Region (2021-2026)
  11. 3.4.3 Global Non-opioid Pain Patch Sales by Region (2027-2032)
  12. 3.4.4 Global Non-opioid Pain Patch Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Non-opioid Pain Patch Revenue by Manufacturers
  2. 4.1.1 Global Non-opioid Pain Patch Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Non-opioid Pain Patch Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Non-opioid Pain Patch Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Non-opioid Pain Patch Sales by Manufacturers
  6. 4.2.1 Global Non-opioid Pain Patch Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Non-opioid Pain Patch Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Non-opioid Pain Patch Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Non-opioid Pain Patch Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Non-opioid Pain Patch Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Non-opioid Pain Patch Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Non-opioid Pain Patch Manufacturers, Product Type & Application
  13. 4.7 Global Non-opioid Pain Patch Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Non-opioid Pain Patch Market CR5 and HHI
  16. 4.8.2 2025 Non-opioid Pain Patch Tier 1, Tier 2, and Tier 3
5 Non-opioid Pain Patch Market by Type
  1. 5.1 Global Non-opioid Pain Patch Revenue by Type
  2. 5.1.1 Global Non-opioid Pain Patch Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Non-opioid Pain Patch Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Non-opioid Pain Patch Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Non-opioid Pain Patch Sales by Type
  6. 5.2.1 Global Non-opioid Pain Patch Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Non-opioid Pain Patch Sales by Type (2021-2032) & (M Pcs)
  8. 5.2.3 Global Non-opioid Pain Patch Sales Market Share by Type (2021-2032)
  9. 5.3 Global Non-opioid Pain Patch Price by Type
6 Non-opioid Pain Patch Market by Application
  1. 6.1 Global Non-opioid Pain Patch Revenue by Application
  2. 6.1.1 Global Non-opioid Pain Patch Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Non-opioid Pain Patch Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Non-opioid Pain Patch Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Non-opioid Pain Patch Sales by Application
  6. 6.2.1 Global Non-opioid Pain Patch Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Non-opioid Pain Patch Sales by Application (2021-2032) & (M Pcs)
  8. 6.2.3 Global Non-opioid Pain Patch Sales Market Share by Application (2021-2032)
  9. 6.3 Global Non-opioid Pain Patch Price by Application
7 Company Profiles
  1. 7.1 Sanofi
  2. 7.1.1 Sanofi Company Information
  3. 7.1.2 Sanofi Business Overview
  4. 7.1.3 Sanofi Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sanofi Non-opioid Pain Patch Product Portfolio
  6. 7.1.5 Sanofi Recent Developments
  7. 7.2 Johnson & Johnson
  8. 7.2.1 Johnson & Johnson Company Information
  9. 7.2.2 Johnson & Johnson Business Overview
  10. 7.2.3 Johnson & Johnson Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Johnson & Johnson Non-opioid Pain Patch Product Portfolio
  12. 7.2.5 Johnson & Johnson Recent Developments
  13. 7.3 Qizheng
  14. 7.3.1 Qizheng Company Information
  15. 7.3.2 Qizheng Business Overview
  16. 7.3.3 Qizheng Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Qizheng Non-opioid Pain Patch Product Portfolio
  18. 7.3.5 Qizheng Recent Developments
  19. 7.4 Novartis
  20. 7.4.1 Novartis Company Information
  21. 7.4.2 Novartis Business Overview
  22. 7.4.3 Novartis Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Novartis Non-opioid Pain Patch Product Portfolio
  24. 7.4.5 Novartis Recent Developments
  25. 7.5 Mylan
  26. 7.5.1 Mylan Company Information
  27. 7.5.2 Mylan Business Overview
  28. 7.5.3 Mylan Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Mylan Non-opioid Pain Patch Product Portfolio
  30. 7.5.5 Mylan Recent Developments
  31. 7.6 Lingrui
  32. 7.6.1 Lingrui Company Information
  33. 7.6.2 Lingrui Business Overview
  34. 7.6.3 Lingrui Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Lingrui Non-opioid Pain Patch Product Portfolio
  36. 7.6.5 Lingrui Recent Developments
  37. 7.7 Huarun 999
  38. 7.7.1 Huarun 999 Company Information
  39. 7.7.2 Huarun 999 Business Overview
  40. 7.7.3 Huarun 999 Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Huarun 999 Non-opioid Pain Patch Product Portfolio
  42. 7.7.5 Huarun 999 Recent Developments
  43. 7.8 GSK
  44. 7.8.1 GSK Company Information
  45. 7.8.2 GSK Business Overview
  46. 7.8.3 GSK Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 GSK Non-opioid Pain Patch Product Portfolio
  48. 7.8.5 GSK Recent Developments
  49. 7.9 Teikoku Seiyaku
  50. 7.9.1 Teikoku Seiyaku Company Information
  51. 7.9.2 Teikoku Seiyaku Business Overview
  52. 7.9.3 Teikoku Seiyaku Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Teikoku Seiyaku Non-opioid Pain Patch Product Portfolio
  54. 7.9.5 Teikoku Seiyaku Recent Developments
  55. 7.10 Nichiban
  56. 7.10.1 Nichiban Company Information
  57. 7.10.2 Nichiban Business Overview
  58. 7.10.3 Nichiban Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Nichiban Non-opioid Pain Patch Product Portfolio
  60. 7.10.5 Nichiban Recent Developments
  61. 7.11 Mentholatum
  62. 7.11.1 Mentholatum Company Information
  63. 7.11.2 Mentholatum Business Overview
  64. 7.11.3 Mentholatum Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Mentholatum Non-opioid Pain Patch Product Portfolio
  66. 7.11.5 Mentholatum Recent Developments
  67. 7.12 Laboratoires Genevrier
  68. 7.12.1 Laboratoires Genevrier Company Information
  69. 7.12.2 Laboratoires Genevrier Business Overview
  70. 7.12.3 Laboratoires Genevrier Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Laboratoires Genevrier Non-opioid Pain Patch Product Portfolio
  72. 7.12.5 Laboratoires Genevrier Recent Developments
  73. 7.13 Hisamitsu
  74. 7.13.1 Hisamitsu Company Information
  75. 7.13.2 Hisamitsu Business Overview
  76. 7.13.3 Hisamitsu Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Hisamitsu Non-opioid Pain Patch Product Portfolio
  78. 7.13.5 Hisamitsu Recent Developments
  79. 7.14 Haw Par
  80. 7.14.1 Haw Par Company Information
  81. 7.14.2 Haw Par Business Overview
  82. 7.14.3 Haw Par Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Haw Par Non-opioid Pain Patch Product Portfolio
  84. 7.14.5 Haw Par Recent Developments
  85. 7.15 Endo
  86. 7.15.1 Endo Company Information
  87. 7.15.2 Endo Business Overview
  88. 7.15.3 Endo Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Endo Non-opioid Pain Patch Product Portfolio
  90. 7.15.5 Endo Recent Developments
  91. 7.16 BLUE-EMU
  92. 7.16.1 BLUE-EMU Company Information
  93. 7.16.2 BLUE-EMU Business Overview
  94. 7.16.3 BLUE-EMU Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 BLUE-EMU Non-opioid Pain Patch Product Portfolio
  96. 7.16.5 BLUE-EMU Recent Developments
  97. 7.17 Actavis
  98. 7.17.1 Actavis Company Information
  99. 7.17.2 Actavis Business Overview
  100. 7.17.3 Actavis Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Actavis Non-opioid Pain Patch Product Portfolio
  102. 7.17.5 Actavis Recent Developments
8 North America
  1. 8.1 North America Non-opioid Pain Patch Market Size by Type
  2. 8.1.1 North America Non-opioid Pain Patch Revenue by Type (2021-2032)
  3. 8.1.2 North America Non-opioid Pain Patch Sales by Type (2021-2032)
  4. 8.1.3 North America Non-opioid Pain Patch Price by Type (2021-2032)
  5. 8.2 North America Non-opioid Pain Patch Market Size by Application
  6. 8.2.1 North America Non-opioid Pain Patch Revenue by Application (2021-2032)
  7. 8.2.2 North America Non-opioid Pain Patch Sales by Application (2021-2032)
  8. 8.2.3 North America Non-opioid Pain Patch Price by Application (2021-2032)
  9. 8.3 North America Non-opioid Pain Patch Market Size by Country
  10. 8.3.1 North America Non-opioid Pain Patch Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Non-opioid Pain Patch Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Non-opioid Pain Patch Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Non-opioid Pain Patch Market Size by Type
  2. 9.1.1 Europe Non-opioid Pain Patch Revenue by Type (2021-2032)
  3. 9.1.2 Europe Non-opioid Pain Patch Sales by Type (2021-2032)
  4. 9.1.3 Europe Non-opioid Pain Patch Price by Type (2021-2032)
  5. 9.2 Europe Non-opioid Pain Patch Market Size by Application
  6. 9.2.1 Europe Non-opioid Pain Patch Revenue by Application (2021-2032)
  7. 9.2.2 Europe Non-opioid Pain Patch Sales by Application (2021-2032)
  8. 9.2.3 Europe Non-opioid Pain Patch Price by Application (2021-2032)
  9. 9.3 Europe Non-opioid Pain Patch Market Size by Country
  10. 9.3.1 Europe Non-opioid Pain Patch Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Non-opioid Pain Patch Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Non-opioid Pain Patch Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China Non-opioid Pain Patch Market Size by Type
  2. 10.1.1 China Non-opioid Pain Patch Revenue by Type (2021-2032)
  3. 10.1.2 China Non-opioid Pain Patch Sales by Type (2021-2032)
  4. 10.1.3 China Non-opioid Pain Patch Price by Type (2021-2032)
  5. 10.2 China Non-opioid Pain Patch Market Size by Application
  6. 10.2.1 China Non-opioid Pain Patch Revenue by Application (2021-2032)
  7. 10.2.2 China Non-opioid Pain Patch Sales by Application (2021-2032)
  8. 10.2.3 China Non-opioid Pain Patch Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Non-opioid Pain Patch Market Size by Type
  2. 11.1.1 Asia Non-opioid Pain Patch Revenue by Type (2021-2032)
  3. 11.1.2 Asia Non-opioid Pain Patch Sales by Type (2021-2032)
  4. 11.1.3 Asia Non-opioid Pain Patch Price by Type (2021-2032)
  5. 11.2 Asia Non-opioid Pain Patch Market Size by Application
  6. 11.2.1 Asia Non-opioid Pain Patch Revenue by Application (2021-2032)
  7. 11.2.2 Asia Non-opioid Pain Patch Sales by Application (2021-2032)
  8. 11.2.3 Asia Non-opioid Pain Patch Price by Application (2021-2032)
  9. 11.3 Asia Non-opioid Pain Patch Market Size by Country
  10. 11.3.1 Asia Non-opioid Pain Patch Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Non-opioid Pain Patch Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Non-opioid Pain Patch Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Non-opioid Pain Patch Market Size by Type
  2. 12.1.1 SAMEA Non-opioid Pain Patch Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Non-opioid Pain Patch Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Non-opioid Pain Patch Price by Type (2021-2032)
  5. 12.2 SAMEA Non-opioid Pain Patch Market Size by Application
  6. 12.2.1 SAMEA Non-opioid Pain Patch Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Non-opioid Pain Patch Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Non-opioid Pain Patch Price by Application (2021-2032)
  9. 12.3 SAMEA Non-opioid Pain Patch Market Size by Country
  10. 12.3.1 SAMEA Non-opioid Pain Patch Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Non-opioid Pain Patch Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Non-opioid Pain Patch Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Non-opioid Pain Patch Value Chain Analysis
  2. 13.1.1 Non-opioid Pain Patch Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Non-opioid Pain Patch Production Mode & Process
  6. 13.2 Non-opioid Pain Patch Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Non-opioid Pain Patch Distributors
  9. 13.2.3 Non-opioid Pain Patch Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst